Treatment of Malignant Melanoma
Treatment of Malignant Melanoma
- A 46-year-old Caucasian female presented one year ago with deep ulcerated primary tumor and multiple involved lymph nodes.
- She was diagnosed with stage IIIC melanoma.
- Patient underwent wide local incision and compete lymph node dissection and appeared to be clear of disease.
- Patient decided not to pursue adjuvant therapy after surgery.
- Six months after surgery, she developed abdominal pain.
- Imaging showed multiple masses in the liver, > 1 cm, scattered pulmonary nodules and some enlarged lymph nodes.
- Tumor biopsy confirmed melanoma and mutational analysis showed BRAF V600E mutation.
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd.
Related Videos
Related Content
Management of Immune-Related Toxicities in Melanoma Has Improved Over Time
April 24th 2024Article
During a Case-Based Roundtable® event, Evan J. Lipson, MD, discussed with participants how their experience with immunotherapy toxicities has changed over time in the first article of a 2-part series.
Read More
Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma
March 14th 2024Article
During a Targeted Oncology™ Case-Based Roundtable™ event, Michael B. Atkins, MD, discussed dosing considerations and toxicity when choosing combination treatment for patients with melanoma. This is the second of 2 articles based on this event.
Read More
